LAVA Therapeutics N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of LAVA Therapeutics N.V. generated cash of -$38,972,000, which is less than the previous year. Cash used in financing activities reached the amount of -$571,000 last year. Net change in cash is therefore -$56,102,000.
Cash Flow
| 2019 | -9.77M | -898.60K | 1.33M |
|---|---|---|---|
| 2020 | -10.40M | -537.48K | 19.73M |
| 2021 | -28.64M | -43.54M | 151.16M |
| 2022 | 4.04M | 9.34M | 283K |
| 2023 | -38.97M | -17.63M | -571K |
LVTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 100.33M | 90.86M | 15.81M | 8.04M | 18.15M |
Operating activities | |||||
Net income | -41.69M | -31.65M | -45.19M | -16.66M | -10.99M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.27M | 781K | 558K | 494.44K | 293.86K |
Stock-based compensation expense | 5.03M | 4.11M | 3.90M | 557K | 217.84K |
| Deferred income tax benefit | 5.03M | 4.11M | 3.90M | 557K | 217.84K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 1.58M | -2.69M | 0 | -1.06M | 37.44K |
Inventories | 0 | 0 | 0 | -424.33K | 0 |
Accounts payable | 334K | 1.41M | 1.61M | 282.88K | -215.57K |
Cash generated by operating activities | -38.97M | 4.04M | -28.64M | -10.40M | -9.77M |
Investing activities | |||||
Purchases Of Investments | -90.08M | -70.87M | -45.29M | 0 | -34.03K |
Investments In Property Plant And Equipment | -730K | -587K | -764K | -537.48K | -864.56K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -17.63M | 9.34M | -43.54M | -537.48K | -898.60K |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 94.18M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -5.16M | -5.01M | 0 |
Repayments of term debt | -571K | 268K | -340K | -257.05K | 1.17M |
Cash used in financing activities | -571K | 283K | 151.16M | 19.73M | 1.33M |
Net Change In Cash | -56.10M | 9.46M | 75.05M | 7.79M | -9.83M |
Cash at end of period | 44.23M | 100.33M | 90.86M | 15.84M | 8.32M |
| Data source | Data source | Data source |